Milan Laboratories Cited Over Quality Control, Sanitary Concerns

Drug Industry Daily
A A
The FDA issued drugmaker Milan Laboratories (India) a Form 483 over quality and sanitation problems observed during an August inspection of the firm’s Navi Mumbai facility.

To View This Article:

Login

Subscribe To Drug Industry Daily